Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 154 results found. Search for [ HIV ]

Results 100 to 120 of 154
Sumeet Chatterjee and Ben Hirschler
Mumbai/London, February 6, 2014
Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent.

Jake Pearson
New York, January 22, 2014
Philanthropists Bill and Melinda Gates pitched an optimistic future for the world's poor and sick in their annual letter Tuesday, arguing passionately against three myths they say hurt efforts to bring people out of poverty, save lives and improve living conditions.

Hyderabad, January 18, 2014
Generic drug maker Aurobindo Pharma has signed a binding offer agreement to acquire commercial operations of Dublin-based Actavis plc in seven Western European countries.
November 19, 2013
A look at recent rulings which can affect you

Associated Press
New York, May 3, 2013
The S&P 500 is up 13 per cent from the start of the year. The Dow is up 14 per cent.
March 11, 2013
The book draws from a potpourri of academic work to show Indians are far from inscrutable.

Associated Press
New Delhi, March 5, 2013
The Intellectual Property Appellate Board has rejected Bayer AG's plea to stop Natco Pharma from producing a cheaper generic version of its patented cancer drug.

E Kumar Sharma
January 2, 2013
The US Food and Drug Administration (FDA) has approved an anti-diarrhoea drug, co-developed by Glenmark Pharmaceuticals and US-based Salix Pharmaceuticals Inc.

New Delhi, December 27, 2012
Aurobindo Pharma says it has received final approval by the US health regulator to manufacture and market Nafcillin for injection used for treating bacterial infections in the American market.

BT Online Bureau
New Delhi, December 18, 2012
Drug firm Aurobindo Pharma has received the US health regulator's final approval to market Abacavir Tablets, used in the treatment of Human Immunodeficiency Virus (HIV), in the American market.

New Delhi, November 8, 2012
The pharma company slashed prices of its three generic cancer drugs - Erlocip, Docetax and Capegard - by up to 64 per cent.

New York, October 25, 2012
From achieving stellar heights in Corporate America to being reduced to a convict in one of the biggest insider trading cases in the US, Indian-American Rajat Gupta's stunning fall from grace has been improbable.

Chandralekha Mukerji
October 4, 2012
The revamp of the unit-linked plan, or Ulip, structure, portability of health plans and pension plan guidelines have already made the industry customer-friendly. Now, Irda has released draft guidelines on life and health insurance to take the process further forward.

Associated Press
Washington, July 17, 2012
The Food and Drug Administration approved the first drug shown to reduce the risk of HIV infection, the latest milestone in the 30-year battle against the virus that causes AIDS.
May 9, 2012
Wipro has announced the acquisition of Australian analytics product firm Promax Applications Group in an all-cash deal of A$35 million, its 17th in the IT business since 2002.

Washington, April 17, 2012
Jim Yong Kim's selection as the next president of the World Bank reaffirms the longstanding tradition of an American leading the Washington-based institution.

Dinesh C. Sharma
New Delhi, March 28, 2012
The landmark decision of the patent office to break the monopoly of Bayer in kidney and liver cancer drugs recently is already having a rippling effect.

E. Kumar Sharma
March 27, 2012
Compulsory licences have brought domestic and multinational pharma companies face to face. Although domestic firms are getting to make cheaper versions of patented drugs, will this be enough to cure the country of its health care ills?

Manasi Mithel
March 19, 2012
Home to the highest concentration of makers of generic drugs, India has been a global source of cheap medicines. But seven years into the product patent regime, affordable access to some lifesaving drugs remains an issue.
April 11, 2012
The Insurance Regulatory and Development Authority wants to curb mis-selling by agents and brokers who ask people to make advance payments to avail of discounts on premiums.

PAGES 6 OF 8  678